This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Align Technology (ALGN) Beats on Earnings and Revenues in Q2
by Zacks Equity Research
Align Technology (ALGN) gains on solid contributions from Clear Aligner as well as Scanner and Service segments in Q2.
Chemed (CHE) Beats on Q2 Earnings & Revenues, View Raised
by Zacks Equity Research
Chemed (CHE) rides on strong contributions from the Roto-Rooter and VITAS businesses in Q2.
Stryker (SYK) Beats on Q2 Earnings, International Sales Up
by Zacks Equity Research
Stryker (SYK) gains from solid segmental performance in Q2.
Medidata (MDSO) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Medidata (MDSO) gains from solid segmental performance in Q2; banks on strategic buyouts.
Boston Scientific (BSX) Beats on Q2 Earnings, Margins Down
by Zacks Equity Research
Boston Scientific (BSX) registers steady growth across all business lines and geographies in Q2.
Look Beyond Earnings: 4 Stocks With Increasing Cash Flows
by Zacks Equity Research
Cash is indispensable to any company. It gives strength and vitality to a company and is the key to its existence, development and success.
Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online
by Zacks Equity Research
Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online
5 Stocks in Focus on New Analyst Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
Quest Diagnostics (DGX) Q2 Earnings Meet, Guidance Narrowed
by Zacks Equity Research
Quest Diagnostics (DGX) gains on successful execution of its two-point strategy of accelerating growth and driving operational excellence in Q2.
5 Low-Beta Stocks to Combat Trade & Geopolitical Tensions
by Nalak Das
The United States and China are yet to reach any sort of understanding to defuse trade tensions between the countries.
Merit Medical (MMSI) Beats on Q2 Earnings, Raises Guidance
by Zacks Equity Research
Merit Medical (MMSI) gains from solid segmental performance in Q2; lifts 2018 guidance.
Zacks.com highlights: Integer Holdings, SunCoke Energy, SHISEIDO, Weight Watchers International and Triton International
by Zacks Equity Research
Zacks.com highlights: Integer Holdings, SunCoke Energy, SHISEIDO, Weight Watchers International and Triton International
PetMed (PETS) Q1 Earnings Lag Estimates, Reorder Sales Solid
by Zacks Equity Research
We are encouraged by growth in PetMed's (PETS) reorder and new order sales in Q1. Increased online sales buoy optimism.
5 Top Stocks With a Handsome Net Profit Margin
by Zacks Equity Research
Five stocks with spectacular net profit margin that can contribute to making a winning portfolio.
Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues
by Zacks Equity Research
Strong performance in the Instruments & Accessories as well as Systems segments drove Intuitive Surgical's (ISRG) top line in Q2.
Neogen (NEOG) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
Neogen (NEOG) sticks to its four-pronged growth strategy for steady progress. Also, the company's accretive buyouts and its broader international base are a boon.
Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up
by Zacks Equity Research
Abbott (ABT) posts another quarter of strong EPD and Medical Devices performance. Particularly, Abbott has been riding high on a healthy growth within its Diabetes Care business.
OPKO Health's RAYALDEE Gets Approval in Canada to Treat CKD
by Zacks Equity Research
OPKO Health's (OPK) partner VFMCRP gets regulatory nod from Health Canada to market flagship RAYALDEE; benefits patients diagnosed with chronic kidney disease.
Zacks.com featured highlights include: Integer Holdings, Louisiana-Pacific, Knight-Swift, Herc and Eaton
by Zacks Equity Research
Zacks.com featured highlights include: Integer Holdings, Louisiana-Pacific, Knight-Swift, Herc and Eaton
5 Stocks to Add to Your Portfolio on Upgraded Broker Ratings
by Zacks Equity Research
After proper research, brokers rate a particular company's stock. So, you can easily depend on their recommendations before making investment decision.
Veeva Systems' Development Cloud Platform Picked by Idorsia
by Zacks Equity Research
Switzerland's Idorsia implements Veeva Systems' (VEEV) Development Cloud. Veeva Systems gains foothold in Europe.
Integer Holdings (ITGR) Catches Eye: Stock Jumps 7.5%
by Zacks Equity Research
Integer Holdings (ITGR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Here's Why You Should Invest in DaVIta (DVA) Stock Right Now
by Zacks Equity Research
Strong fundamentals and solid international presence make DaVita (DVA) a lucrative pick.
ITGR vs. ABMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITGR vs. ABMD: Which Stock Is the Better Value Option?
Zacks.com highlights: Movado Group, BRT Apartments, Integer Holdings, Hollysys Automation Technologies and QuinStreet
by Zacks Equity Research
Zacks.com highlights: Movado Group, BRT Apartments, Integer Holdings, Hollysys Automation Technologies and QuinStreet